background
rhinoviru
rv
caus
common
cold
asthma
exacerb
rv
genom
kb
singlestrand
positivesens
rna
object
use
minor
group
backbon
sought
design
gener
recombin
accommod
fluoresc
marker
express
therebi
allow
track
viral
infect
recombin
infecti
cdna
clone
harbor
code
sequenc
green
fluoresc
protein
gfp
renilla
luciferas
ilov
light
oxygen
voltag
sens
engin
construct
rvinfect
cell
determin
flow
cytometri
immunohistochemistri
immunofluoresc
microscopi
result
show
cytopath
effect
hela
cell
fail
express
gfp
renilla
luciferas
due
delet
smaller
fluoresc
protein
construct
stabli
express
infect
cell
express
use
examin
antivir
effect
bafilomycin
hela
cell
compar
parent
viru
infect
balbc
mice
yield
similar
viral
load
level
cytokin
mrna
express
howev
imag
fix
lung
tissu
fail
reveal
fluoresc
signal
like
due
oxid
bleach
ilovbound
flavin
mononucleotid
therefor
employ
antiilov
antibodi
immunohistochem
immunofluoresc
imag
ilov
signal
identifi
airway
epitheli
cell
lung
macrophag
result
suggest
use
molecular
tool
studi
rv
pathogenesi
construct
strategi
could
appli
rv
serotyp
howev
detect
ilovexpress
rv
fix
tissu
requir
use
antiilov
antibodi
limit
valu
construct
fluoresc
tag
ilov
picornaviru
revers
genet
rhinoviru
rhinoviru
rv
frequent
viral
infecti
agent
respiratori
tract
human
predomin
caus
common
cold
importantli
rv
emerg
frequent
pathogen
associ
asthma
exacerb
infant
children
adult
rv
place
picornavirida
famili
genu
enteroviru
three
speci
base
phylogenet
sequenc
criteria
clinic
specimen
collect
yield
approxim
differ
speci
b
strain
subsequ
serotyp
recent
divers
group
previous
unrecogn
human
virus
speci
c
found
common
caus
respiratori
ill
understand
rv
pathogenesi
human
anim
model
develop
human
studi
employ
experiment
infect
mous
studi
use
wildtyp
mice
mice
transgen
human
intercellular
adhes
model
particularli
use
studi
rvinduc
exacerb
allerg
airway
diseas
detect
rv
tissu
investig
employ
monoclon
antibodi
antibodi
origin
develop
waim
lee
univers
wisconsin
bind
capsid
protein
close
relat
strain
presenc
differ
rv
serotyp
make
infeas
develop
crossreact
antibodi
rv
sought
develop
recombin
viru
fluoresc
marker
could
use
track
rv
infect
vivo
similar
picornavirus
rv
icosahedr
nonenvelop
particl
compos
copi
four
capsid
protein
small
myristoyl
capsid
encas
positivesens
singlestrand
rna
ssrna
genom
approxim
nucleotid
follow
viru
entri
genom
releas
host
cell
cytoplasm
rv
ssrna
translat
singl
polyprotein
undergo
proteolyt
cleavag
viral
proteas
pro
pro
except
autocatalyt
cleavag
precursor
presenc
viral
rna
assembl
process
rv
infecti
cdna
clone
construct
use
molecular
tool
studi
rv
viral
protein
function
mutationphenotyp
associ
well
vaccin
vector
foreign
gene
express
current
studi
engin
recombin
insert
code
sequenc
ilov
light
oxygen
voltag
sens
smallsiz
fluoresc
marker
viabl
express
ilov
protein
trackabl
vitro
vivo
suggest
may
use
tool
studi
rv
pathogenesi
howev
detect
ilovexpress
rv
fix
tissu
requir
use
antiilov
antibodi
limit
valu
construct
cell
purchas
atcc
manassa
va
plasmid
clontech
mountain
view
ca
prl
renilla
luciferas
promega
madison
wi
genscript
piscataway
nj
use
amplifi
dna
fragment
green
fluoresc
protein
gfp
renilla
luciferas
rl
ilov
respect
detail
ilov
nucleotid
sequenc
see
tabl
antibodi
rv
obtain
qed
bioscienc
san
diego
ca
antigfp
ab
purchas
thermo
fisher
scientif
waltham
synthes
peptid
fragment
ilov
clgrnarflqgpetd
gener
use
gener
antiilov
antibodi
genscript
bafilomycin
purchas
merck
millipor
burlington
rv
infecti
cdna
clone
encod
replicationcompet
kindli
provid
w
jackson
univers
maryland
serv
backbon
either
gfp
rl
ilovexpress
virus
gfp
rl
ilov
open
read
frame
orf
design
flank
edit
nucleotid
sequenc
encod
viral
pro
cleavag
site
silent
mutat
introduc
describ
previous
figur
tabl
respect
gfp
rl
ilov
insert
pcr
amplifi
exist
clone
use
primer
list
tabl
pcr
product
contain
apa
restrict
enzym
cleavag
site
end
digest
apa
ligat
transform
e
coli
thermo
fisher
scientif
result
clone
sequenc
confirm
correct
orient
insert
infecti
cdna
clone
encod
linear
mlu
restrict
enzym
digest
produc
replicationcompet
viru
fulllength
viral
rna
transcript
gener
use
megascript
transcript
kit
thermo
fisher
scientif
transfect
cell
use
lipofectamin
messengermax
thermo
fisher
scientif
hour
cell
underw
three
freezethaw
cycl
subject
centrifug
g
supernat
collect
viruscontain
supernat
stock
design
passag
cell
subsequ
use
passag
viru
subsequ
vitro
viru
stabil
vivo
studi
underw
plaqu
purif
insert
analysi
rv
concentr
partial
purifi
infect
hela
cell
lysat
ultrafiltr
use
kda
cutoff
filter
describ
viral
quantiti
determin
plaqu
assay
quantit
onestep
realtim
polymeras
chain
reaction
positivestrand
viral
rna
use
rvspecif
primer
probe
forward
primer
revers
primer
probe
limit
detect
viral
copi
number
analysi
copi
presenc
gfp
rl
ilov
insert
determin
use
rvspecif
flank
primer
forward
primer
revers
primer
ilov
insert
quantiti
measur
quantit
realtim
pcr
use
specif
primer
encod
ilov
forward
primer
revers
primer
clone
qed
bioscienc
imag
visual
use
olympu
phaseepifluoresc
microscop
digit
ccd
camera
lung
rna
extract
trizol
reagent
thermo
fisher
scientif
combin
oncolumn
digest
genom
dna
qiagen
valencia
ca
cdna
synthes
rna
subject
quantit
realtim
pcr
use
specif
mrna
primer
encod
tabl
sampl
level
gene
express
normal
gapdh
mrna
data
repres
mean
se
statist
signific
assess
use
unpair
test
oneway
anova
appropri
group
differ
pinpoint
tukey
multiplecomparison
test
gfp
flank
pro
cleavag
site
design
insert
rv
genom
sequenc
encod
protein
figur
stabil
genom
silent
mutat
introduc
code
sequenc
flank
pro
cleavag
site
tabl
describ
previous
gener
viral
stock
genom
rna
transcript
made
infecti
clone
transfect
cell
follow
three
consecut
passag
cytopath
effect
cpe
observ
hela
cellinfect
figur
howev
unabl
detect
gfp
express
western
blot
figur
examin
presenc
intact
gfp
rl
orf
rtpcr
perform
plaquepurifi
use
rvspecif
flank
primer
result
show
gfp
rl
sequenc
delet
figur
sequenc
analysi
insert
confirm
result
data
shown
reason
approxim
nt
gfp
nt
rl
orf
includ
engin
flank
sequenc
exceed
limit
packag
capac
rv
therefor
chose
altern
smaller
fluoresc
protein
ilov
nt
gener
follow
design
gener
procedur
cpe
growth
kinet
determin
hela
cell
comparison
parent
viru
display
slightli
reduc
cytopath
effect
growth
rate
figur
b
immunofluoresc
ilov
signal
green
appear
cell
confirm
express
ilov
figur
western
blot
analysi
use
rabbit
sera
recogn
ilov
protein
show
express
product
predict
molecular
weight
cell
figur
viral
capsid
protein
detect
cell
next
examin
genet
stabil
hela
cell
stock
rtpcr
reveal
exogen
ilov
dna
stabli
retain
within
rv
genom
five
passag
figur
sequenc
analysi
ilov
insert
confirm
result
reveal
mutat
data
shown
explor
applic
antivir
drug
screen
bafilomycin
previous
shown
inhibit
rv
f
g
u
r
e
gfp
orf
insert
rhinoviru
genom
delet
schemat
present
insert
gfp
rv
genom
rv
protein
present
box
pro
cleavag
point
indic
yellow
solid
triangl
separ
rv
structur
nonstructur
protein
releas
gfp
protein
solid
blue
arrow
indic
pro
cleavag
site
b
plaqu
morpholog
hela
cell
infect
parent
wildtyp
c
western
blot
analysi
wholecel
lysat
hela
cell
infect
sampl
probe
presenc
gfp
rv
structur
protein
gfp
input
made
wholecel
lysat
hela
cell
detect
cell
livecel
imag
immunofluoresc
stain
hela
cell
infect
moi
either
sham
h
hela
cell
transfect
h
bar
rv
protein
detect
use
ab
red
ilov
green
directli
detect
blue
laser
nuclei
stain
dapi
shown
black
bar
e
rtpcr
analysi
rvgfp
rvrl
genom
rvgfp
rvrl
genom
rna
isol
plaquepurifi
viru
stock
infecti
cdna
clone
use
templat
amplif
complet
gfp
rl
sequenc
infect
previous
show
minor
group
viru
trigger
inflamm
cytokin
express
mice
therefor
test
whether
ilov
insert
influenc
rv
replic
rvinduc
inflammatori
respons
vivo
eightweekold
mice
infect
day
lung
harvest
dif
tabl
retent
ilov
insert
approxim
indic
time
point
figur
c
next
examin
cytokin
mrna
express
mice
lung
harvest
one
day
infect
similar
parent
viru
increas
lung
mrna
level
ifng
figur
howev
ifng
mrna
express
decreas
compar
perhap
slightli
reduc
growth
rate
induct
observ
either
hela
cell
plate
coverslip
infect
fix
paraformaldehyd
fluoresc
signal
visual
signal
rapidli
quench
like
due
oxid
bleach
ilovbound
flavin
mononucleotid
similarli
imag
fix
lung
tissu
mice
fail
reveal
fluoresc
signal
therefor
employ
antiilov
antibodi
immunohistochem
stain
immunofluoresc
f
g
u
r
e
construct
infecti
recombin
rhinovirusilov
plaqu
morpholog
hela
cell
infect
parent
wildtyp
ilov
green
express
directli
detect
blue
laser
rv
plaqu
b
viral
copi
number
titer
rvinfect
hela
cell
cell
infect
moi
specifi
time
cell
harvest
analysi
viral
copi
number
analyz
quantit
polymeras
chain
reaction
viral
titer
determin
tcid
n
mean
sd
c
fluoresc
imag
rvilov
hela
cell
infect
parent
wildtyp
h
moi
rv
protein
detect
use
ab
red
ilov
green
directli
detect
blue
laser
nuclei
stain
dapi
shown
black
bar
western
blot
assay
detect
express
ilov
f
g
u
r
e
stabil
livecel
imag
immunofluoresc
stain
hela
cell
hela
cell
infect
h
moi
rv
protein
detect
use
ab
red
ilov
green
directli
detect
blue
laser
nuclei
stain
dapi
shown
black
bar
b
number
ilovposit
cell
cell
count
cell
ilovposit
c
ilov
detect
hela
cell
flow
cytometri
cell
transfect
infect
harvest
h
later
analyz
percentag
singl
cell
n
mean
sem
e
rtpcr
analysi
genom
parent
genom
rna
isol
hela
cell
infect
viru
stock
infecti
cdna
clone
use
templat
amplif
complet
ilov
sequenc
imag
infect
mice
harvest
lung
one
day
postinfect
previous
shown
besid
airway
epitheli
cell
rv
coloc
macrophag
immunohistochem
stain
antiilov
show
signal
epithelium
macrophag
figur
immunofluoresc
similarli
indic
local
airway
epithelium
well
coloc
ilov
green
red
macrophag
marker
blue
figur
previous
shown
rv
infect
induc
lung
infiltr
exud
macrophag
analysi
intracellular
ilov
aliquot
lung
minc
fix
permeabil
incub
antiilov
prior
flow
cytometri
flow
cytometr
analysi
show
similar
increas
percentag
cell
mice
figur
confirm
coloc
lung
macrophag
rv
howev
signal
detect
cell
mice
taken
togeth
result
suggest
potenti
tool
studi
rvinduc
respons
immatur
mice
present
studi
sought
design
gener
recombi
construct
recombin
virus
express
fluoresc
marker
especi
gfp
appli
revers
genet
rna
virus
includ
influenza
viru
zika
viru
west
nile
viru
respiratori
syncyti
viru
murin
coronaviru
porcin
reproduct
respiratori
syndrom
viru
howev
insert
larg
fluoresc
protein
code
sequenc
genom
picornavirus
group
small
rna
virus
whose
genom
size
rang
kb
problemat
insert
gfp
orf
polioviru
sever
impair
viral
replic
delet
cours
cell
cultur
serial
passag
addit
attempt
construct
recombin
footandmouth
diseas
viru
fmdv
express
gfp
renilla
luciferas
protein
fail
like
due
limit
packag
capabl
subsequ
construct
virus
contain
increasingli
larger
insert
suggest
nt
f
g
u
r
e
presenc
ilov
signal
airway
epithelium
lung
macrophag
mice
twentyfour
hour
infect
lung
fix
formaldehyd
overnight
embed
paraffin
section
incub
dilut
antiilov
isotyp
control
igg
bar
b
lung
section
costain
antiilov
green
red
far
red
optic
spectrum
shown
blue
c
lung
ilov
cell
rvinfect
balbc
mice
identifi
one
day
postinfect
analyz
percentag
cell
n
one
experi
data
present
mean
sem
differ
sham
p
oneway
anova
maximum
size
insert
fmdv
genom
consist
use
express
fragment
hiv
gag
gene
shorter
antigen
tag
also
insert
nonstructur
protein
polioviru
compar
gfp
fluoresc
protein
base
flavinbind
lov
light
oxygen
voltag
sens
domain
offer
advantag
owe
smaller
size
nt
ph
thermal
stabil
similar
viral
protein
ilov
protein
releas
rv
polyprotein
viral
proteinasemedi
autocleavag
viral
protein
product
earli
step
viral
replic
detect
ilov
mous
tissu
therefor
highli
suggest
viral
replic
particularli
airway
epithelium
howev
remain
unclear
whether
ilov
signal
macrophag
repres
replic
engulf
viru
phagocytosi
viral
replic
cultur
macrophag
limit
though
recent
shown
airway
epitheli
cell
promot
rhinoviru
replic
monocyt
cell
differ
rv
serotyp
speci
b
alon
infeas
develop
crossreact
antibodi
rv
one
antibodi
avail
purpos
monoclon
antibodi
antibodi
bind
capsid
protein
close
relat
strain
develop
recombin
viru
fluoresc
marker
could
use
track
rv
infect
vivo
design
ilov
sequenc
flank
pro
cleavag
site
insert
rv
genom
sequenc
encod
protein
pro
mediat
autocleavag
protein
sinc
selfcatalyt
cleavag
characterist
picornaviru
replic
design
allow
extens
techniqu
human
rv
given
fact
ilov
sequenc
stabli
maintain
within
genom
consecut
passag
plausibl
rv
serotyp
would
accommod
maintain
stabil
ilov
sequenc
though
pro
cleavag
site
numer
rv
serotyp
heterogen
design
flank
pro
cleavag
sequenc
serotypespecif
would
guarante
releas
ilov
besid
cleavag
site
junction
site
nterminu
use
insert
gfp
genom
coxsacki
viru
howev
insert
impair
viral
replic
taken
togeth
data
suggest
construct
strategi
could
appli
rv
serotyp
studi
life
cycl
rv
cultur
cell
screen
antivir
drug
pathogenesi
rv
author
thank
dr
william
jackson
univers
maryland
school
medicin
gift
infecti
cdna
clone
author
also
thank
dr
waim
lee
biolog
mimet
construct
critic
research
work
support
nih
funder
role
studi
design
data
collect
interpret
decis
submit
work
public
http
